ANI PHARMACEUTICALS, INC Class of Warrant or Right, Outstanding
ANI PHARMACEUTICALS, INC (ANIP) had Class of Warrant or Right, Outstanding of 2.20 million shares as of 2015-09-30, per its 10-Q filed 2015-11-03.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2015-11-03
- 2015-09-30: Class of Warrant or Right, Outstanding 2.20M shares.
- 2015-06-30: Class of Warrant or Right, Outstanding 2.40M shares.
- 2015-03-31: Class of Warrant or Right, Outstanding 2.50M shares.
- 2014-12-31: Class of Warrant or Right, Outstanding 2.50M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2015-09-30 | 2.20M shares 10-Q · filed 2015-11-03 |
| 2015-06-30 | 2.40M shares 10-Q · filed 2015-08-04 |
| 2015-03-31 | 2.50M shares 10-Q · filed 2015-05-05 |
| 2014-12-31 | 2.50M shares 10-K · filed 2015-02-23 |
| 2014-09-30 | 469.00K shares 10-Q · filed 2014-11-10 |
| 2014-06-30 | 535.00K shares 10-Q · filed 2014-08-07 |
| 2014-03-31 | 555.00K shares 10-Q · filed 2014-05-12 |
| 2013-12-31 | 686.00K shares 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |